MedTrace Logo

Comparison Of Efficacy and Safety Between Ticagrelor and Clopidogrel In Chinese

NCT03239067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9040

Last updated 2021-11-29

No results posted yet for this study

Summary

This is a prospective, single-center study to assess the long- and short-term outcomes of ticagrelor vs clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Patients will undergo face-to-face interviews, phone calls, or/and chart reviews at 7 days, 1 month, 6 months and 12 months. When 4500 patients have completed the follow-up, an interim analysis will be performed.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Dao Wen Wang, Doctor · Tongji Hospital,Wuhan, Hubei, China, 430030

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-01
Primary Completion
2021-10-24
Completion
2021-10-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03239067 on ClinicalTrials.gov